London, United Kingdom – 07 Nov – 09 Nov 2019
MAP 2019 – Molecular Analysis for Personalised Therapy is a unique meeting established by global opinion leaders. The congress aims to integrate insights from tumour sample analysis into daily practice.
The MAP Congress has grown into an influential, highly interactive forum which is a natural choice for specialists working in precision medicine in oncology. The Congress programme is based on the genomic information obtained through the sequencing of all tumours and the tumour environment.
Organised by Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, the MAP Congress is the result of an enduring collaborative effort and offers its delegates the very latest thinking in the field.
We look forward to seeing you in London in 2019 !
Learn more about this event
London, United Kingdom, 07 Nov – 09 Nov 2019
The congress will take place at the Queen Elisabeth II Centre, located in the heart of Westminster.
Registration fees can be found on the congress website at esmo.org. Registration includes access to the Congress sessions, delegate bag material and welcome reception.
Any questions about registration should be directed to firstname.lastname@example.org.